India is thinking of reviewing Pfizer Inc and AstraZeneca’s vaccines for unexpected emergency use on an accelerated foundation, a senior government official said on Monday.
Serum Institute is making AstraZeneca’s Covid-19 vaccine in India and has used for unexpected emergency use authorization.
Pfizer used for unexpected emergency use authorization of its coronavirus vaccine about the weekend, the official said.
“We are in the process of reviewing. It is an accelerated reviewing process, which is there for Serum far too,” the government official said. “All programs are accelerated. It is the want of the hour.”